Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis

Review Article

Abstract

Background and aims

Pulmonary hypertension (PH) has been suggested to be associated with systemic lupus erythematosus (SLE). However, the results of prevalence studies on PH in SLE vary substantially. To derive a more precise estimation on the prevalence of PH in SLE, a meta-analysis was performed.

Methods

Relevant literatures were searched in PubMed and EMBASE until November 2017. A total of 1366 articles were obtained after searching databases, and 23 studies were finally included in the meta-analysis. Heterogeneity test was performed, and publication bias was evaluated.

Results

The result of analysis in random effect model showed that the pooled prevalence was 8% (95%CI 5–12%). There was no evidence of publication bias (p = 0.51). To evaluate the stability of our results, sensitivity analyses were performed, and the results showed no significant change when any one study was excluded. Subgroup analyses demonstrated that there were significant differences in PH prevalence in SLE patients of different gender, age, regions, year of publication, and diagnostic methods.

Conclusions

PH is prevalent in SLE patients, but it was significantly different between different gender, age, regions, year of publication, and diagnostic methods.

Keywords

Meta-analysis Prevalence study Pulmonary hypertension Systemic lupus erythematosus 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    Ni J, Qiu L-J, L-F H (2014) Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis. Lupus 23(3):284–292.  https://doi.org/10.1177/0961203313520060 CrossRefPubMedGoogle Scholar
  2. 2.
    Perez-Penate GM, Rua-Figueroa I, Julia-Serda G, Leon-Marrero F, Garcia-Quintana A, Ortega-Trujillo JR et al (2016) Pulmonary arterial hypertension in systemic lupus erythematosus: prevalence and predictors. J Rheumatol 43(2):323–329.  https://doi.org/10.3899/jrheum.150451 CrossRefPubMedGoogle Scholar
  3. 3.
    Lang IM, Bonderman D, Skoro-Sajer N, Klepetko W, Kneussl M (2003) Pulmonary hypertension in rheumatic diseases. Z Rheumatol 62(1):2–9.  https://doi.org/10.1007/s00393-003-0477-z CrossRefPubMedGoogle Scholar
  4. 4.
    Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A et al (2009) Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54(1):S55–S66.  https://doi.org/10.1016/j.jacc.2009.04.011 CrossRefPubMedGoogle Scholar
  5. 5.
    Crowhurst JA, Plaat F (1999) Why mothers die. Report on confidential enquiries into maternal deaths in the United Kingdom 1997-9. Anaesthesia 54(3):207–209.  https://doi.org/10.1046/j.1365-2044.1999.00854.x CrossRefPubMedGoogle Scholar
  6. 6.
    Weiss BM, Zemp L, Seifert B, Hess OM (1998) Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 31(7):1650–1657.  https://doi.org/10.1016/S0735-1097(98)00162-4 CrossRefPubMedGoogle Scholar
  7. 7.
    Weiss BM, Hess OM (2000) Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives. Eur Heart J 21(2):104–115.  https://doi.org/10.1053/euhj.1999.1701 CrossRefPubMedGoogle Scholar
  8. 8.
    P C (1973) Primary pulmonary hypertension and SLE. N Engl J Med 288(20):1078–1079.  https://doi.org/10.1056/NEJM197305172882018 CrossRefGoogle Scholar
  9. 9.
    Charoenpan P, Sukumalchantra Y, Ayuthya WI (1977) Pulmonary hypertension in systemic lupus erythematosus: a case report. J Med Assoc Thail 60:670–675Google Scholar
  10. 10.
    Perez HD, Kramer N (1981) Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature. Semin Arthritis Rheum 11(1):177–181.  https://doi.org/10.1016/0049-0172(81)90098-6 CrossRefPubMedGoogle Scholar
  11. 11.
    Bijl M, Bootsma H, Kallenberg CG (2009) Pulmonary arterial hypertension in systemic lupus erythematosus: should we bother? Rheumatology (Oxford) 48(12):1471–1472.  https://doi.org/10.1093/rheumatology/kep258 CrossRefGoogle Scholar
  12. 12.
    Ling-Te Pan T, Thumhoo J, Boey M-L (2000) Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus 9:338–342CrossRefGoogle Scholar
  13. 13.
    Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH (1954) Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine 33(4):291–437.  https://doi.org/10.1097/00005792-195412000-00001 CrossRefPubMedGoogle Scholar
  14. 14.
    Johnson SR, Gladman DD, Urowitz MB, Ibañez D, Granton JT (2004) Pulmonary hypertension in systemic lupus. Lupus 13(7):506–509.  https://doi.org/10.1191/0961203303lu1051oa CrossRefPubMedGoogle Scholar
  15. 15.
    Sanchez O, Humbert M, Sitbon O, Simonneau G (1999) Treatment of pulmonary hypertension secondary to connective tissue diseases. Thorax 54(3):273–277.  https://doi.org/10.1136/thx.54.3.273 CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Charles H (2004) Pulmonary hypertension associated with systemic lupus erythematosus. Bulletin De Lacadémie Nationale De Médecine 188:985–997 discussion 997Google Scholar
  17. 17.
    Xia YK, SH T, YH H, Wang Y, Chen Z, Day HT et al (2013) Pulmonary hypertension in systemic lupus erythematosus: a systematic review and analysis of 642 cases in Chinese population. Rheumatol Int 33(5):1211–1217.  https://doi.org/10.1007/s00296-012-2525-y CrossRefPubMedGoogle Scholar
  18. 18.
    Winslow TM, Ossipov MA, Fazio GP, Simonson JS et al (1995) Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 129:510–515CrossRefPubMedGoogle Scholar
  19. 19.
    Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M, STROBE Initiative (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 18(6):805–835.  https://doi.org/10.1097/EDE.Ob013e3181577511 CrossRefPubMedGoogle Scholar
  20. 20.
    Luo ML, Tan HZ, Zhou Q et al (2013) Realizing the meta-analysis of single rate in R software. The. J Evid -Based Med 13(3):181–184Google Scholar
  21. 21.
    Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560.  https://doi.org/10.1136/bmj.327.7414.557 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Lewis S (2001) Forest plots: trying to see the wood and the trees. BMJ 322:1479–1480CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Elias Badui, David Garcia-Rubi, Elsa Robles, Javier Jimenez, Lourdes Juan, Margarita Deleze, et al. (1985) Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology-Journal of Vascular Diseases 431–442Google Scholar
  24. 24.
    Tanaka E, Harigai M, Tanaka M, Kawaguchi Y, Hara M, Kamatani N (2002) Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment. J Rheumatol 29(2):282–287PubMedGoogle Scholar
  25. 25.
    Chung SM, Lee CK, Lee EY, Yoo B, Lee SD, Moon HB (2006) Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension. Clin Rheumatol 25(6):866–872.  https://doi.org/10.1007/s10067-006-0206-5 CrossRefPubMedGoogle Scholar
  26. 26.
    Quadrelli SA, Alvarez C, Arce SC, Paz L, Sarano J, Sobrino EM, Manni J (2009) Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies. Lupus 18(12):1053–1060.  https://doi.org/10.1177/0961203309106601 CrossRefPubMedGoogle Scholar
  27. 27.
    Prabu A, Patel K, Yee CS, Nightingale P, Situnayake RD, Thickett DR, Townend JN, Gordon C (2009) Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. Rheumatology (Oxford) 48(12):1506–1511.  https://doi.org/10.1093/rheumatology/kep203 CrossRefGoogle Scholar
  28. 28.
    Foïs E, Le Guern V, Dupuy A, Humbert M, Mouthon L, Guillevin L (2010) Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: retrospective analysis of 93 patients. Clin Exp Rheumatol 28:836–841PubMedGoogle Scholar
  29. 29.
    Bourré-Tessier J, Huynh T, Clarke AE, Bernatsky S, Joseph L, Belisle P et al (2011) Features associated with cardiac abnormalities in systemic lupus erythematosus. Lupus 20:1518–1525CrossRefPubMedGoogle Scholar
  30. 30.
    Kamel SR, Omar GM, Darwish AF, Asklany HT, Ellabban AS (2011) Asymptomatic pulmonary hypertension in systemic lupus erythematosus. Clin Med Insights Arthritis Musculoskelet Disord 4:77–86.  https://doi.org/10.4137/CMAMD.S7667 CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Cefle A, Inanc M, Sayarlioglu M, Kamali S, Gul A, Ocal L, Aral O, Konice M (2011) Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome. Rheumatol Int 31(2):183–189.  https://doi.org/10.1007/s00296-009-1255-2 CrossRefPubMedGoogle Scholar
  32. 32.
    Akdogan A, Kilic L, Dogan I, Okutucu S, Er E, Kaya B, Coplu L, Calguneri M, Tokgozoglu L, Ertenli I (2013) Pulmonary hypertension in systemic lupus erythematosus: pulmonary thromboembolism is the leading cause. J Clin Rheumatol 19(8):421–425.  https://doi.org/10.1097/RHU.0000000000000037 CrossRefPubMedGoogle Scholar
  33. 33.
    Ruiz-Irastorza G, Garmendia M, Villar I, Egurbide MV, Aguirre C (2013) Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy. Autoimmun Rev 12:410–415CrossRefPubMedGoogle Scholar
  34. 34.
    Li M, Wang Q, Zhao J, Li Z, Ye Z, Li C, Li X, Zhu P, Wang Z, Zheng Y, Li X, Zhang M, Tian Z, Liu Y, He J, Zhang F, Zhao Y, Zeng X, CSTAR co-authors (2014) Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus. Lupus 23(10):1085–1091.  https://doi.org/10.1177/0961203314527366 CrossRefPubMedGoogle Scholar
  35. 35.
    Lee JH, Im Cho K (2014) Arterial stiffness, antiphospholipid antibodies, and pulmonary arterial hypertension in systemic lupus erythematosus. J Cardiol 64(6):450–455.  https://doi.org/10.1016/j.jjcc.2014.02.030 CrossRefPubMedGoogle Scholar
  36. 36.
    Ki-Jo KIM, In-Woon BAEK, Yune-Jung PARK, Chong-Hyeon YOON, Wan-Uk KIM, CHO C-S (2015) High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension. International Journal of Rheumatic Diseases 524–532Google Scholar
  37. 37.
    Ware D, Sharma V, Kalekar L, Kamble A, Mahajan A, Gokhale Y (2015) Higher incidence of pulmonary hypertension in antiphospholipid antibody positive lupus. J Assoc Physicians India 63(4):17–20PubMedGoogle Scholar
  38. 38.
    Hamdani MA, Saud Al-Arfaj AR, Parvez K, Naseeb F, Ibrahim Ael F, Cal JH (2015) Pulmonary manifestations of systemic lupus erythematosus patients with and without antiphospholipid syndrome. Pak J Med Sci 31(1):70–75.  https://doi.org/10.12669/pjms.311.6544 PubMedPubMedCentralGoogle Scholar
  39. 39.
    Hachulla E, Jais X, Cinquetti G, Clerson P, Rottat L, Launay D, et al. (2017) Pulmonary arterial hypertension associated with systemic lupus erythematosus: results from the French Pulmonary Hypertension Registry. ChestGoogle Scholar
  40. 40.
    Ghofraniha L, Mirfeizi Z, Khabbaz FS, Vakilian F, Eslami S (2017) Correlation of echocardiographic findings of pulmonary hypertension with six-minute walk test and plasma pro b-type natriuretic peptide level in systemic lupus erythematous. Electron Physician 9(8):5122–5128CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Luo RQ, Lei YX, Zhang X, Fei L (2008) Clinical analysis of patients with systemic lupus erythematosus and concomitant pulmonary hypertension. J South Med Univ 28:1860–1863Google Scholar
  42. 42.
    Xing Y, Song HM, Wu XY, He YY, Min W (2008) Clinical analysis and pulmonary arterial hypertension secondary to connective tissue disease in children. CLIN J Pedistr 46:822–826Google Scholar
  43. 43.
    Ye D, Pan F, Zhang K, Li X, Xu J, Hao J (2006) A novel single-nucleotide polymorphism of the Fcgamma receptor IIIa gene is associated with genetic susceptibility to systemic lupus erythematosus in Chinese populations: a family-based association study. Clin Exp Dermatol 31(4):553–557.  https://doi.org/10.1111/j.1365-2230.2006.02133.x CrossRefPubMedGoogle Scholar
  44. 44.
    Li-Ju Chen, Hung-Chou Chang, Ling-Ying Lu, Jui-Cheng Tseng, Jui-Chieh Hu, Chien-Kai Kau, et al(2004) Prolonged survival after single lung transplantation for pulmonary hypertension secondary to systemic lupus erythematosus. J Chin Med Assoc 248-251Google Scholar
  45. 45.
    Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G (2006) Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173(9):1023–1030.  https://doi.org/10.1164/rccm.200510-1668OC CrossRefPubMedGoogle Scholar
  46. 46.
    Hsu VM, Moreyra AE, Wilson AC et al (2008) Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. J Rheumatol 35(3):458–465PubMedGoogle Scholar
  47. 47.
    Mukerjee D, St George D, Knight C, Davar J, Wells AU, du Bois RM, Black CM, Coghlan JG (2004) Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology 43(4):461–466.  https://doi.org/10.1093/rheumatology/keh067 CrossRefPubMedGoogle Scholar
  48. 48.
    Asherson RA, Higenbottam TW, Dinh Xuan AT et al (1990) Pulmonary hypertension in a lupus clinic. Experience with twenty-four patients. J Rheumatol 17(10):1292–1298PubMedGoogle Scholar
  49. 49.
    Robbins IM, Gaine SP, Schilz R, Tapson VF, Rubin LJ, Loyd JE (2000) Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus. Chest 117(1):14–18.  https://doi.org/10.1378/chest.117.1.14 CrossRefPubMedGoogle Scholar

Copyright information

© Royal Academy of Medicine in Ireland 2017

Authors and Affiliations

  • Tian-Tian Lv
    • 1
    • 2
  • Peng Wang
    • 1
    • 2
  • Shi-Yang Guan
    • 1
    • 2
  • Hong-Miao Li
    • 1
    • 2
  • Xiao-Mei Li
    • 3
  • Bin Wang
    • 1
    • 2
  • Hai-Feng Pan
    • 1
    • 2
  1. 1.Department of Epidemiology and Biostatistics, School of Public HealthAnhui Medical UniversityHefeiPeople’s Republic of China
  2. 2.Anhui Province Key Laboratory of Major Autoimmune DiseasesHefeiChina
  3. 3.Department of RheumatologyAnhui Provincial HospitalHefeiChina

Personalised recommendations